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Intravital multiphoton microscopy has provided powerful mechanistic insights into health and disease and has become a common instrument in the modern biological laboratory. The requisite high numerical aperture and exogenous contrast agents that enable multiphoton microscopy, however, limit the ability to investigate substantial tissue volumes or to probe dynamic changes repeatedly over prolonged periods. Here we introduce optical frequency domain imaging (OFDI) as an intravital microscopy that circumvents the technical limitations of multiphoton microscopy and, as a result, provides unprecedented access to previously unexplored, crucial aspects of tissue biology. Using unique OFDI-based approaches and entirely intrinsic mechanisms of contrast, we present rapid and repeated measurements of tumor angiogenesis, lymphangiogenesis, tissue viability and both vascular and cellular responses to therapy, thereby demonstrating the potential of OFDI to facilitate the exploration of physiological and pathological processes and the evaluation of treatment strategies.
The application of multiphoton microscopy (MPM) 1, 2 to the study of solid tumor biology in vivo has elucidated pathways and mechanisms of cancer progression and has led to new therapeutic strategies 3 . Current high-resolution intravital imaging techniques, however, permit visualization of tumor microstructure and vascular morphology only superficially (300-400-µm depth) and only over volumetric regions that are a fraction of the total tumor volume in small animal models. Additionally, longitudinal imaging is often limited in frequency, owing to the accumulation of exogenous contrast agents. Consequently, nearly a decade after the introduction of MPM to tumor biology, considerable gaps remain in our understanding of the vascularization of tumors, the multifaceted interactions between tissues and vessels within the heterogeneous tumor mass, and the response of blood vessels, lymphatic vessels and cancer cells to therapy. New methods that complement existing MPM techniques by probing the tumor microenvironment over wider fields and broader time scales are needed to fill these gaps.
Optical coherence tomography (OCT) 4 is an alternative approach for in vivo microscopy that supports imaging at these expanded spatiotemporal scales. However, methods for effectively characterizing biological parameters of the tumor microenvironment and structure are lacking in OCT, and existing angiographic OCT systems have not achieved the high sensitivity and the rapid imaging speeds required for large-volume vascular morphometry. Here we overcome these limitations by developing new methods and instrumentation for a second-generation OCT technology termed OFDI 5 . We apply these techniques to a range of tumor models in vivo and demonstrate the ability of OFDI to perform high-resolution, wide-field and deep imaging of tumor vasculature; morphological and fractal characterization of vascular networks; contrast-free functional lymphangiography; and characterization of tissue viability. Furthermore, we show that application of these capabilities reveals the responses of tumors in vivo to vascular-targeted and cellular-targeted therapies.
RESULTS
We characterized the microenvironment of multiple tumor models at varying sites in mice using OFDI. We developed the imaging system ( Supplementary Fig. 1 ) in house to scan a focused laser beam onto the tissue sample while recording the reflected optical signals. Crosssectional images were provided in real-time, and we used post-processing to provide three-dimensional perspectives and quantitative analysis of biological parameters (Fig. 1a and Supplementary Fig. 2 ).
Wide-field three-dimensional angiography
The microvasculature of solid tumors has a crucial role in both progression and response to therapy 6 . To detect vessels in OCT, contrast Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging is derived from the Doppler shift [7] [8] [9] [10] [11] [12] induced by circulating red blood cells. Using new implementations of Doppler principles and OFDI 13 , we enabled wide-field angiography with sufficient speed to perform imaging over wide-fields and sensitivity to map smaller vessels and specificity to discriminate vascular motion from physiological motion (Supplementary Methods). We derived three-dimensional angiographic datasets from the acquired OFDI signals and reduced them to en face vascular projections using color to encode depth (Fig. 1b) . We obtained vascular projections across multiple tumor types at various sites ( Supplementary Figs. 3 and 4) and, additionally, in normal tissues, including the mammary fat pad and marrow space within the calvarium (Supplementary Fig. 5 ).
To provide gross perspective of the relative merits and complementary nature of Doppler OFDI and MPM angiography, we imaged tumors sequentially with each modality (Fig. 2 and Supplementary Methods). Whereas MPM excelled at visualizing the smallest superficial capillaries (Fig. 2e,f) , Doppler OFDI was superior in discerning vessels deeper within the central regions of the tumor and in regions where fluorescent tracers extravasated (Fig. 2c,d) . We routinely observed vessels beyond 1.0 mm in depth with Doppler OFDI (Fig. 1b) , whereas with MPM the maximum penetration depth in the surveyed tumor models ranged from 250 to 400 µm (Fig. 2b) . The unique Doppler acquisition techniques incorporated into the OFDI instrument allowed rapid visualization of the tumor vasculature inclusive of its connectivity with host vessels, complementing the higher resolution but relatively superficial angiography provided by MPM.
Morphological and fractal characterization of vascular networks
Morphological characterization of blood vessels in tumors provides insight into resistance to transport, angiogenic mechanisms and response to therapy 14, 15 . Previous characterization methods, based on intravital microscopy and MPM angiography, have been limited to small fields of view and superficial depths. To extract quantitative vascular measurements from the OFDI angiograms, we developed a fully automated three-dimensional vascular tracing and analysis algorithm, optimized specifically to operate on the OFDI datasets (Supplementary Methods). The algorithm reduced threedimensional OFDI angiograms to networks of interconnected vessel segments modeled as superellipsoids 16 . From the centerlines and shape parameters of these superellipsoids, we extracted the trajectories and morphology of vessel segments (Supplementary Fig. 6 ). A comparison of co-registered vessel segment diameters derived from (Fig. 2g,h ) indicated a high correlation (r = 0.87) for vessels measuring larger than 12 µm in diameter by MPM (Fig. 2i) . For capillaries smaller than 12 µm in diameter, OFDI methods often located and traced the vessel segments but overestimated diameters, resulting in a lower correlation (r = 0.36).
The ability of OFDI to extract vascular parameters over larger volumes presents new opportunities for network characterization. Fractal analysis has been invoked to quantify the ability of a vascular network to provide an efficient transport of blood-borne nutrients, oxygen or drugs within the tumor 14 . The fractal dimension is a statistical measure indicating how completely a network fills space. In threedimensional geometries, an optimal space-filling network has a fractal dimension of three; lower fractal dimensions indicate a lesser degree of space filling. Using the topology and branching patterns derived from the OFDI data sets, we have analyzed the three-dimensional fractal dimension of tumor vasculature in vivo (Supplementary Methods). An analysis of the vascular network depicted in Figure 1b yielded a fractal dimension of 2.74 in the tumor region, in agreement with results expected from previous two-dimensional analyses, and 3.02 in a normal region of the right hemisphere, consistent with a fully developed capillary network filling three-dimensional space 17, 18 ( Supplementary Fig. 7 ).
Lymphangiography
Lymphangiography is typically performed by injecting a visible or fluorescent dye and imaging uptake and drainage via the lymphatic vessels. This approach, however, obscures structures near the site of injection and highlights only those lymphatic vessels draining the region of the injection. In OFDI, lymphatic networks appear as structures with negligible scattering intensity. The reduced scattering of the lymph relative to surrounding tissue is probably associated with its hypocellularity (Fig. 3a) . Using these scattering characteristics, we identified, mapped and segmented lymphatic vessels in the OFDI data sets (Supplementary Methods). OFDI images of lymphatic networks in normal mouse skin showed functional lymphatic vessels highlighted with conventional Evan's blue lymphangiography, as well as additional vessels draining other regions of the skin (Fig. 3b,c) . We observed enlarged peritumoral lymphatics for human sarcoma models growing in the dorsal skin fold of mice (81 ± 4 µm; <2 mm from tumor versus 40 ± 3 µm; >2 mm from tumor: P < 0.05), consistent with previous measurements 19, 20 (Fig. 3d) . OFDI crosssectional images were helpful in identifying cellular masses within the lymphatics (Fig. 3e) . By eliminating the need for exogenous contrast agents, OFDI allowed the monitoring of functional lymphatic vessels throughout tumor progression (Supplementary Fig. 8) . Notably, OFDI lymphangiography can be performed simultaneously with OFDI angiography (Supplementary Fig. 3) ; the two techniques differ only in the methods for post-processing of the OFDI data. 
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Imaging tissue viability
Cell-targeted therapies are traditionally studied through assessment of tumor growth delay and histological examinations. These techniques, however, have their inherent limitations. Through the dependence of tissue scattering on cellular structures 21 , it is possible to differentiate necrotic or apoptotic regions within a tumor from viable regions in three dimensions using OFDI. We found higherscattering regions within a murine mammary carcinoma (MCaIV) to correspond to necrotic regions defined by H&E staining (Fig. 4a) . We observed these regions to expand, encompassing an increasing fraction of tumor volume during tumor progression (Fig. 4b,c) .
Multiparametric monitoring of therapeutic response
To demonstrate OFDI's capacity to reveal the tumor response to therapy, we monitored changes induced by vascular or cellular targeted therapy. In the first set of experiments, we imaged mice with MCaIV tumors every other day up to 9 d during treatment with vascular endothelial growth factor receptor-2 (VEGFR-2)-blocking monoclonal antibody DC101. Control mice with the same tumor preparation received nonspecific rat IgG. We imaged every 2 d after implantation and defined starting points for each mouse on the basis of the status of the vascular network and the tumor volume. OFDI measurements of pretreatment and control mean vessel diameters in 11 total tumors were consistent with previously published results using MPM 22 (55.8 ± 3.4 µm versus 49.8 ± 5.1 µm, respectively). OFDI angiograms, acquired at day 5, consistently showed a more dense and chaotic vascular network in the control group relative to the treated group (Fig. 5a) . We found a reduction in both mean intratumor vessel length (P = 0.001) and diameter (P = 0.029) with DC101 treatment, consistent with the findings of the previous study 22 (Fig. 5b) . At day 7, the mean tumor volume within the treated group was 25% of that in the control group (Fig. 5b) . The geometrical properties of the tumor vascular network showed a less pronounced response between groups. The fractal dimensions of both treatment and control groups reached plateaus (2.54 ± 0.04 and 2.60 ± 0.01, respectively) at day 3, and the mean tortuosity (see Supplementary Methods) in the treated group was slightly lower than that of the control group at the conclusion of the study (Fig. 5b) .
To observe short timescale vascular dynamics induced by antiangiogenic therapy, we imaged MCaIV tumors growing in the dorsal skin fold chamber every 4 h for 48 h. We administered either DC101 or nonspecific rat IgG immediately after the initial imaging session. Promptly after VEGFR-2 blockade, the mean vessel diameter began to decrease, whereas the tumor volume continued to expand. These trends continued throughout the 48-h time course of the study ( Supplementary  Figs. 9 and 10) . Time-lapse images of vascular responses acquired every 2 h for 48 h highlight the unprecedented ability of OFDI to monitor vascular dynamics over wide fields (Supplementary Video 1) .
In the second set of experiments, we applied OFDI to investigate direct targeting of tumor cells. Diphtheria toxin accumulates in human cells, halting protein synthesis and eventually inducing apoptosis, but does not affect murine cells 23, 24 . Therefore, in mouse xenograft models, diphtheria toxin can be used to model a cytotoxic treatment that is not confounded by direct damage to vascular endothelial cells. When we administered diphtheria toxin into mice bearing a human colorectal adenocarcinoma xenograft (LS174T) grown in the dorsal skin chamber, apoptosis was evident within 2 d through associated changes in tumor-scattering properties (Fig. 5c) . During the first 24 h, the tumor volume remained approximately constant (Fig. 5d) . After 24 h, we observed widespread necrotic or apoptotic regions within the volume of the treated tumors, and the mean tumor volume began to decrease rapidly. After 48 h, the intratumor vessel length rapidly decreased, presumably as a result of the downregulation or depletion of tumor cell-derived angiogenic growth factors (Fig. 5d) .
DISCUSSION
Through the development of new techniques, instrumentation and algorithms, we have demonstrated the unique capabilities of OFDI to image the microenvironment of tumors in vivo rapidly and persistently over time without requiring exogenous contrast agents. These capabilities provide a new tool to probe the dynamics of tumor growth and response to therapy over substantially more 
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of the tumor volume than can be accessed by higher resolution approaches such as MPM. As such, OFDI bridges a gap between subcellular resolution optical microscopies and alternative techniques, such as Doppler ultrasonography, magnetic resonance imaging and microcomputed tomography, which can penetrate deeper into tissue but are limited to resolutions above ~50 µm.
Our results show frequent angiographic imaging over extended periods in the context of therapeutic intervention is possible using OFDI. Furthermore, the ability to perform tracer-free lymphangiography of functional lymphatic networks with OFDI is a key advance in the field that allows dynamic monitoring of the lymphatic vasculature during cancer progression and lymphedema 20, 25 . The unique capability of OFDI to longitudinally image tissue viability and to spatially register this information with tumor vasculature opens new possibilities for the evaluation of existing therapeutic approaches and the rational design of therapeutic regimens. In concert, these capabilities present a powerful tool that complements and is likely to become as widely used as MPM in the study of solid tumors and the screening and development of vascular targeted and cellular targeted agents in cancer therapy.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/.
ONLINE METHODS
Optical frequency domain imaging system, signal and image processing, and quantitative analysis. OFDI provides high resolution imaging of the elastic light scattering properties of a sample in three dimensions 5 . Beam focusing provides transverse (x,y) discrimination of signals. Interferometric measurements of optical delay gate signals across the axial (z) dimension. The measurements first sample in parallel the interference signal between light scattered at all detectable depths and an external reference beam as a function of wavelength. Subsequent Fourier analysis of this interference signal across wavelength separates the combined signals across all depths into a depth-resolved scattering profile. The construction and design of the OFDI system (Supplementary Fig. 1 ) and the algorithms used to derive images from the OFDI data set and extract quantitative data are described in the Supplementary Methods.
Mouse models. We prepared dorsal skinfold chambers and mammary fat pad windows in severe combined immunodeficient mice implanted in the center of the chamber 2-3 d after the initial surgery 26, 27 . We transplanted the murine mammary adenocarcinoma (MCaIV, generated in our laboratory), human colorectal adenocarcinoma (LS174T, ATCC CL188), and human soft tissue sarcoma (HSTS26T) from subcutaneous tumors grown in isogenic mice. We implanted the human mammary adenocarcinoma (MDA-MB-361HK) as a single-cell suspension of ~3 × 10 6 cells in 30 µl of HBSS (Gibco). We prepared cranial windows in nude mice as previously described 28 and implanted either human glioblastoma multiforme (U87) tumor tissue 400 microns deep in the posterior cortex or MCaIV tissue in the leptomeninges of the left hemisphere. We generally allowed tumors to grow for 2 weeks to a size of 4 mm in diameter by en face measurement depending on the experimental protocol. We anesthetized the mice with either ketamine and xylene (10 mg ml -1 and 1 mg ml -1 , respectively) or isoflurane (1% in 100% oxygen), as indicated in the Supplementary Methods for each specific experiment. All mice were bred and maintained in Massachusetts General Hospital animal facilities, and the work was approved by the Massachusetts General Hospital Institutional Animal Care and Use Committee.
VEGFR-2 blockade. We administered DC101 (ImClone Systems) or nonspecific rat IgG intraperitoneally at 40mg per kg body weight as prescribed in previous studies 22 . We imaged the mice every 2 d beginning 5 or 6 d after tumor implantation. We determined therapeutic initiation through monitoring of tumor growth by both visual inspection and OFDI angiography. We selected mice for the study on the basis of the following criteria: the maximum tumor diameter was approximately 4 mm in diameter by en face measurement, the entire margin of the tumor was functionally vascularized and the mouse was in good health. We randomly assigned the mice to treatment groups and masked the assignment during the duration of therapy to remove bias. We gave three treatments at 3-d intervals (defined as day 0, day 3 and day 6), and we imaged through day 9. We calculated tumor growth delay from measurements of tumor volume by OFDI microanatomy measurements.
Cytotoxic therapy. We administered diphtheria toxin (Sigma-Aldrich) intraperitoneally at 30 µg per kg body weight as previously described 24 . For control mice, we injected a similar volume of saline intraperitoneally. We treated male SCID mice bearing human colorectal adenocarcinoma tumors in the dorsal skinfold chamber once and monitored them over 10 d. During the initial 24 h, we made OFDI multiparametric measurements every 12 h followed by measurements every other day as described in the Supplementary Methods. Prolonged time-lapse imaging. We performed imaging under gas anesthesia (1% isoflurane in oxygen) every 4 h for 48 h in mice bearing MCaIV mouse mammary carcinoma tumors in the dorsal skinfold chamber. Each imaging session was 5-10 min in duration, between which we returned the experimental mouse to its cage. We administered DC101 or nonspecific rat IgG (40 mg per kg body weight intraperitoneally) once after the first imaging session. To generate the shorter interval time-lapse video, we imaged a separate SCID mouse bearing MCaIV in the dorsal skinfold chamber every 2 h for 48 h. We administered DC101 (40 mg per kg body weight intraperitoneally) once 8 h after the first imaging session. We manually cropped and aligned the resulting angiographic images for each time point with Adobe Photoshop (Adobe Systems) and ImageJ (US National Institutes of Health) to generate the time-lapse video.
Evans blue lymphangiography. We performed lymphangiography by injecting 10 µl of 4% Evans blue (Sigma) into the tissue and observing nearby lymphatic vessels with a dissecting scope.
Statistical analyses.
Data are presented as means ± s.e.m. We determined significant differences between groups by a multivariate repeated measures analysis of variance accounting for response to treatment over time (Systat, Systat Software). For quantitative metrics calculated by the vascular tracing algorithm, such as vascular diameters, we determined significant differences at each time point by a two-sample Student's t test. For tumor growth, we determined statistical differences at each time point by the nonparametric Mann-Whitney test. We denoted statistical differences at given time points on the plots by asterisks. We considered a P value ≤ 0.05 significant for all comparisons. We compared the multiphoton and OFDI measurements of vessel diameters (Fig. 2i) with the Pearson product-moment correlation. 
